v3.25.3
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Net revenue $ 1,335,582 $ 1,224,509
Cost of sales (exclusive of amortization shown separately below) 506,941 499,620
Amortization of acquired intangible assets 7,821 7,670
Total cost of sales 514,762 507,290
Gross profit 820,820 717,219
Operating Expenses    
Selling, general, and administrative 259,194 238,979
Research and development 87,323 79,524
Amortization of acquired intangible assets 11,956 11,404
Restructuring expenses (note 11) 15,810 0
Total operating expenses 374,283 329,907
Income from operations 446,537 387,312
Other income (loss), net:    
Interest (expense) income, net 8,793 (1,661)
Gain (loss) attributable to equity method investments (note 5) 1,489 963
Gain (loss) on equity investments (note 5) (6,190) (680)
Other, net (3,836) (2,437)
Total other income (loss), net 256 (3,815)
Income before income taxes 446,793 383,497
Income taxes 98,257 72,142
Net income $ 348,536 $ 311,355
Basic earnings per share (in dollars per share) $ 2.38 $ 2.12
Diluted earnings per share (in dollars per share) 2.37 2.11
Dividend declared per share (in dollars per share) $ 0.60 $ 0.53
Basic shares outstanding (000's) (in shares) 146,182 146,861
Diluted shares outstanding (000's) (in shares) 146,899 147,599
Sleep and Breathing Health    
Net revenue $ 1,169,446 $ 1,067,737
Cost of sales (exclusive of amortization shown separately below) 456,118 451,312
Amortization of acquired intangible assets 1,420 1,210
Residential Care Software    
Net revenue 166,136 156,772
Cost of sales (exclusive of amortization shown separately below) 50,823 48,308
Amortization of acquired intangible assets $ 6,401 $ 6,460

Source